185 related articles for article (PubMed ID: 32783116)
1. Targeting Serotonin 5-HT
Kantrowitz JT
CNS Drugs; 2020 Sep; 34(9):947-959. PubMed ID: 32783116
[TBL] [Abstract][Full Text] [Related]
2. Pimavanserin exhibits serotonin 5-HT
Muneta-Arrate I; Diez-Alarcia R; Horrillo I; Meana JJ
Eur Neuropsychopharmacol; 2020 Jul; 36():83-89. PubMed ID: 32517960
[TBL] [Abstract][Full Text] [Related]
3. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K
Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097
[TBL] [Abstract][Full Text] [Related]
4. The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug.
Jalal B
Psychopharmacology (Berl); 2018 Nov; 235(11):3083-3091. PubMed ID: 30288594
[TBL] [Abstract][Full Text] [Related]
5. Serotonin 5-HT
Gener T; Tauste Campo A; Alemany-González M; Nebot P; Delgado-Sallent C; Chanovas J; Puig MV
Neuropharmacology; 2019 Nov; 158():107743. PubMed ID: 31430459
[TBL] [Abstract][Full Text] [Related]
6. ACS chemical neuroscience molecule spotlight on Fanapt.
Hopkins CR
ACS Chem Neurosci; 2010 Jun; 1(6):410. PubMed ID: 22778835
[TBL] [Abstract][Full Text] [Related]
7. Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow.
Frånberg O; Marcus MM; Svensson TH
Synapse; 2012 Jul; 66(7):650-60. PubMed ID: 22362425
[TBL] [Abstract][Full Text] [Related]
8. Role of prefrontal cortical 5-HT
Mitazaki S; Nakagawasai O; Onogi H; Watanabe K; Takahashi K; Tan-No K; Quirion R; Srivastava LK; Tadano T
Behav Brain Res; 2020 Jan; 377():112226. PubMed ID: 31521737
[TBL] [Abstract][Full Text] [Related]
9. Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation.
Kraehenmann R; Pokorny D; Vollenweider L; Preller KH; Pokorny T; Seifritz E; Vollenweider FX
Psychopharmacology (Berl); 2017 Jul; 234(13):2031-2046. PubMed ID: 28386699
[TBL] [Abstract][Full Text] [Related]
10. Augmentation With Pimavanserin in Treatment Refractory Schizophrenia: Case Report.
Lindenmayer JP; Rizvi S
J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):337-339. PubMed ID: 33857029
[No Abstract] [Full Text] [Related]
11. Serotonin 2A receptor antagonists for treatment of schizophrenia.
Ebdrup BH; Rasmussen H; Arnt J; Glenthøj B
Expert Opin Investig Drugs; 2011 Sep; 20(9):1211-23. PubMed ID: 21740279
[TBL] [Abstract][Full Text] [Related]
12. Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density.
Lian J; Huang XF; Pai N; Deng C
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():62-8. PubMed ID: 23994047
[TBL] [Abstract][Full Text] [Related]
13. Serotonin 5-HT
García-Bea A; Miranda-Azpiazu P; Muguruza C; Marmolejo-Martinez-Artesero S; Diez-Alarcia R; Gabilondo AM; Callado LF; Morentin B; González-Maeso J; Meana JJ
Eur Neuropsychopharmacol; 2019 Dec; 29(12):1453-1463. PubMed ID: 31734018
[TBL] [Abstract][Full Text] [Related]
14. d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.
De Gregorio D; Comai S; Posa L; Gobbi G
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886063
[TBL] [Abstract][Full Text] [Related]
15. Role of the serotonin 5-HT(2A) receptor in learning.
Harvey JA
Learn Mem; 2003; 10(5):355-62. PubMed ID: 14557608
[TBL] [Abstract][Full Text] [Related]
16. Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine D₂ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats.
Oyamada Y; Horiguchi M; Rajagopal L; Miyauchi M; Meltzer HY
Behav Brain Res; 2015 May; 285():165-75. PubMed ID: 25448429
[TBL] [Abstract][Full Text] [Related]
17. The crosstalk between 5-HT
Saha S; González-Maeso J
Neuropharmacology; 2023 Jun; 230():109489. PubMed ID: 36889432
[TBL] [Abstract][Full Text] [Related]
18. Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT
M Ro Rsted E; Jensen AA; Smits G; Frydenvang K; Kristensen JL
J Med Chem; 2024 May; 67(9):7224-7244. PubMed ID: 38648420
[TBL] [Abstract][Full Text] [Related]
19. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).
Schindler EA; Dave KD; Smolock EM; Aloyo VJ; Harvey JA
Pharmacol Biochem Behav; 2012 Mar; 101(1):69-76. PubMed ID: 22197710
[TBL] [Abstract][Full Text] [Related]
20. Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease.
McFarland K; Price DL; Bonhaus DW
Behav Pharmacol; 2011 Oct; 22(7):681-92. PubMed ID: 21921840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
